WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations

Simple item page
dc.contributor.authorSingh, J.A.
dc.contributor.authorKochhar, S.
dc.contributor.authorWolff, J.
dc.contributor.authorAtuire, C.
dc.contributor.authorBhan, A.
dc.contributor.authorEmanuel, E.
dc.contributor.authorFaden, R.
dc.contributor.authorGhimire, P.
dc.contributor.authorGreco, D.
dc.contributor.authorHo, C.
dc.contributor.authorMoon, S.
dc.contributor.authorShamsi-Gooshki, E.
dc.contributor.authorTouré, A.
dc.contributor.authorThomé, B.
dc.contributor.authorSmith, M.J.
dc.contributor.authorUpshur, R.E.G.
dc.date.accessioned2022-04-27T08:09:05Z
dc.date.available2022-04-27T08:09:05Z
dc.date.issued2022
dc.descriptionResearch Articleen_US
dc.description.abstractWhile the degree of COVID-19 vaccine accessibility and uptake varies at both national and global levels, increasing vaccination coverage raises questions regarding the standard of prevention that ought to apply to different settings where COVID-19 vaccine trials are hosted. A WHO Expert Group has developed guidance on the ethical implications of conducting placebo-controlled trials in the context of expanding global COVID-19 vaccine coverage. The guidance also considers alternative trial designs to placebo controlled trials in the context of prototype vaccines, modified vaccines, and next generation vaccinesen_US
dc.identifier.otherhttps://doi.org/10.1016/j.vaccine.2022.02.038
dc.identifier.urihttp://ugspace.ug.edu.gh/handle/123456789/37958
dc.language.isoenen_US
dc.publisherVaccineen_US
dc.subjectPlacebo-controlled trialsen_US
dc.subjectStandard of careen_US
dc.subjectStandard of preventionen_US
dc.subjectTrial designsen_US
dc.subjectResearch ethicsen_US
dc.titleWHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerationsen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access Ethical considerations.pdf
Size:
367.42 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Department of Philosophy and Classics